BLOG: High expectations for melanoma drug ipilimumab
I wrote about the cancer drug ipilimumab last year, which has been hailed as miraculous by some. The drug has been through Phase 3 clinical trials and results will be presented on June 6 at the annual meeting of the American Society of Clinical Oncology (ASCO). Meanwhile, following announcements of the miracle cure in three [...]
Read More